EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications
Beth Israel Deaconess Medical Center · Harvard University
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
598
total citations
- FWCI
- 28.35
- Percentile
- 100%
- References
- 80
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- Gefitinib
- Afatinib
- Exon
- Erlotinib
- Neratinib
- Epidermal growth factor receptor
- Lung cancer
- Cancer research
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.